Liao Ye, Yang Chunsheng, Bakeer Banu
Medical Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, Sichuan.
Department of Rehabilitation Medicine, The First Affiliation Hospital of Xinjiang Medical University, Urumqi, PR China.
Medicine (Baltimore). 2021 May 7;100(18):e25571. doi: 10.1097/MD.0000000000025571.
Prior reports have suggested that the red blood cell distribution width (RDW) parameter could be measured as a prognostic indicator in pulmonary embolism (PE) patients, thereby helping to guide their care. However, no systematic analyses on this topic have been completed to date, and the exact relationship between RDW and PE remains to be fully clarified. We will therefore conduct a systematic literature review with the goal of defining the correlation between RDW and mortality in acute PE cases.
The EMBASE, Web of Knowledge, PubMed, ClinicalTrials.gov, and Cochrane Library databases will be searched for all relevant studies published from inception through March 2021 using the following search strategy: ("red blood cell distribution width") AND ("pulmonary embolism"). Two authors will independently identify eligible studies and extract data. The Q and I2 statistics will be used to judge heterogeneity among studies.
This study will establish the relative efficacy of RDW as a metric for predicting PE patient mortality.
This study will offer a reliable, evidence-based foundation for the clinical utilization of RDW as a tool for gauging mortality risk in acute PE patients.
As this is a protocol for a systematic review of previously published data, no ethical approval is required. Electronic dissemination of study results will be done through a peer-review publication or represented at a related conference.
先前的报告表明,红细胞分布宽度(RDW)参数可作为肺栓塞(PE)患者的预后指标进行测量,从而有助于指导对他们的治疗。然而,迄今为止尚未完成关于该主题的系统分析,RDW与PE之间的确切关系仍有待充分阐明。因此,我们将进行一项系统的文献综述,目的是确定急性PE病例中RDW与死亡率之间的相关性。
将使用以下检索策略在EMBASE、Web of Knowledge、PubMed、ClinicalTrials.gov和Cochrane图书馆数据库中检索从创刊到2021年3月发表的所有相关研究:(“红细胞分布宽度”)AND(“肺栓塞”)。两名作者将独立识别符合条件的研究并提取数据。Q统计量和I²统计量将用于判断研究之间的异质性。
本研究将确定RDW作为预测PE患者死亡率指标的相对有效性。
本研究将为临床应用RDW作为评估急性PE患者死亡风险的工具提供可靠的循证基础。
由于这是一项对先前发表数据进行系统评价的方案,无需伦理批准。研究结果将通过同行评审出版物进行电子传播,或在相关会议上展示。